Cargando…

Sympathomodulation in Heart Failure with High vs. Normal Ejection Fraction

BACKGROUND: Despite recent advances in the treatment of heart failure with preserved ejection fraction (HFpEF), the overall outcome is poor and evidence-based therapeutic options are scarce. So far, the only evidence-based therapy in HFpEF, sodium glucose linked transporter 2 inhibitors, has only in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fengler, Karl, Kresoja, Karl-Patrik, Rommel, Karl-Philipp, Rosch, Sebastian, Roeder, Maximilian v., Desch, Steffen, Thiele, Holger, Lurz, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242566/ https://www.ncbi.nlm.nih.gov/pubmed/37288333 http://dx.doi.org/10.1016/j.shj.2022.100073

Ejemplares similares

Twenty‐Four‐Month Blood Pressure Results After Renal Denervation Using Endovascular Ultrasound
por: Rosch, Sebastian, et al.
Publicado: (2023)

Deep learning detects heart failure with preserved ejection fraction using a baseline electrocardiogram
por: Unterhuber, Matthias, et al.
Publicado: (2021)

Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure
por: von Roeder, Maximilian, et al.
Publicado: (2021)

Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
por: Rosch, Sebastian, et al.
Publicado: (2020)

Comparison of Long‐Term Outcomes for Responders Versus Non‐Responders Following Renal Denervation in Resistant Hypertension
por: Fengler, Karl, et al.
Publicado: (2021)

Fate of iatrogenic atrial septal defects following mitral transcatheter edge-to-edge repair – a subanalysis of the MITHRAS trial
por: Blazek, Stephan, et al.
Publicado: (2022)

Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials
por: Kresoja, Karl-Patrik, et al.
Publicado: (2023)

Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction
por: Besler, Christian, et al.
Publicado: (2021)

A cardiologist’s guide to machine learning in cardiovascular disease prognosis prediction
por: Kresoja, Karl-Patrik, et al.
Publicado: (2023)

Extracellular volume fraction correlates with myocardial stiffness and allows for differentiation between impaired active relaxation and passive stiffness in heart failure with preserved ejection fraction
por: Rommel, Karl-Philipp, et al.
Publicado: (2016)

Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension
por: Fengler, Karl, et al.
Publicado: (2017)

Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure
por: Lurz, Philipp, et al.
Publicado: (2019)

Impact of Ejection Fraction on long-term outcome after ST-Elevation Myocardial Infarction - comparison between cardiac magnetic resonance imaging and transthoracic echocardiography
por: de Waha, Suzanne, et al.
Publicado: (2012)

Tubulin expression and modification in heart failure with preserved ejection fraction (HFpEF)
por: Schulz, Lisa, et al.
Publicado: (2022)

Short‐Term Effects of Different Transcatheter Edge‐to‐Edge Devices on Mitral Valve Geometry
por: Rosch, Sebastian, et al.
Publicado: (2023)

Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy
por: Obradovic, Danilo Momira, et al.
Publicado: (2022)

Arginine metabolism and nitric oxide turnover in the ZSF1 animal model for heart failure with preserved ejection fraction
por: Büttner, Petra, et al.
Publicado: (2021)

Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension
por: Fengler, Karl, et al.
Publicado: (2017)

Optical Coherence Tomography to Evaluate Plaque Burden and Morphology in Patients With Takotsubo Syndrome
por: Eitel, Ingo, et al.
Publicado: (2016)

The potential role of plasma miR‐155 and miR‐206 as circulatory biomarkers in inflammatory cardiomyopathy
por: Obradovic, Danilo, et al.
Publicado: (2021)

Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
por: Stein, Anna, et al.
Publicado: (2022)

Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction - insights from cardiac magnetic resonance imaging
por: de Waha, Suzanne, et al.
Publicado: (2015)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

Prevalence of Symptomatic Heart Failure with Reduced and with Normal Ejection Fraction in an Elderly General Population–The CARLA Study
por: Tiller, Daniel, et al.
Publicado: (2013)

Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction
por: Desch, Steffen, et al.
Publicado: (2011)

Impact of CMR parameters on prognosis after ST-elevation myocardial infarction - a comparison to traditional outcome markers
por: de Waha, Suzanne, et al.
Publicado: (2012)

Thermodilution vs estimated Fick cardiac output measurement in an elderly cohort of patients: A single-centre experience
por: Kresoja, Karl-Patrik, et al.
Publicado: (2019)

Heart Failure With Preserved Ejection Fraction vs. Reduced Ejection Fraction　― Mechanisms of Ventilatory Inefficiency During Exercise in Heart Failure ―
por: Tsujinaga, Shingo, et al.
Publicado: (2020)

Systems Biology Applied to Heart Failure With Normal Ejection Fraction
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2014)

Phenotyping of Sleep‐Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction—the SchlaHF Registry
por: Arzt, Michael, et al.
Publicado: (2017)

Time-dependency, predictors and impact on outcome of infarct transmurality assessed by magnetic resonance imaging in patients with st-elevation myocardial infarction reperfused by primary percutaneous intervention
por: de Waha, Suzanne, et al.
Publicado: (2011)

Relationship and prognostic value of microvascular obstruction and infarct size in st-elevation myocardial infarction as visualized by magnetic resonance imaging
por: de Waha, Suzanne, et al.
Publicado: (2011)

Impact of gender on the prevalence and extent of microvascular obstruction after st-elevation myocardial infarction
por: de Waha, Suzanne, et al.
Publicado: (2011)

Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine
por: de Waha, Suzanne, et al.
Publicado: (2014)

Characteristics, prognosis, and treatment response in HFpEF patients with high vs. normal ejection fraction
por: Gu, Jun, et al.
Publicado: (2022)

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Relevance of Chronic Total Occlusion for Outcome of Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy
por: Lurz, Julia Anna, et al.
Publicado: (2022)

Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction
por: Büttner, Petra, et al.
Publicado: (2022)

Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction
por: Büttner, Petra, et al.
Publicado: (2023)

Circulating Galectin-3 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Sub-Study of the SHOCK-COOL Trial
por: Cheng, Wenke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mjujgvap4mqdpce64u4mivsmkf